{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Upper+Extremity&page=3", "query": { "condition": "Upper Extremity", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 4188, "total_pages": 419, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Upper+Extremity&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Upper+Extremity&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-26T07:39:10.854Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04673877", "title": "Vancomycin Tissue Concentrations by Bier Block or Intravenous Administration", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Infection", "Hand Injury Wrist", "Hand Injuries", "Hand Injuries and Disorders", "Hand Arthritis" ], "interventions": [ { "name": "Systemic IV Vancomycin", "type": "DRUG" }, { "name": "Bier Block", "type": "PROCEDURE" }, { "name": "Vancomycin", "type": "DRUG" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2021-08-26", "completion_date": "2022-08-17", "has_results": false, "last_update_posted_date": "2022-10-07", "last_synced_at": "2026-10-26T07:39:10.854Z", "location_count": 1, "location_summary": "Phoenix, Arizona", "locations": [ { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT04673877" }, { "nct_id": "NCT03585101", "title": "A Single-arm Evaluation of the Effect of HCV Treatment on Cardiovascular Disease Risk", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hepatitis C" ], "interventions": [ { "name": "Elbasvir/grazoprevir", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, Los Angeles", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2018-08", "completion_date": "2020-04", "has_results": false, "last_update_posted_date": "2018-08-07", "last_synced_at": "2026-10-26T07:39:10.854Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03585101" }, { "nct_id": "NCT00752297", "title": "Safety and Efficacy Study of PurTox® Botulinum Toxin Type A to Treat Frown Lines Between the Eyebrows", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Glabellar Rhytides" ], "interventions": [ { "name": "Preservative-free Saline", "type": "DRUG" }, { "name": "Mentor Purified Toxin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mentor Worldwide, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 402, "start_date": "2007-06", "completion_date": "2008-05", "has_results": false, "last_update_posted_date": "2011-09-12", "last_synced_at": "2026-10-26T07:39:10.854Z", "location_count": 1, "location_summary": "Santa Barbara, California", "locations": [ { "city": "Santa Barbara", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00752297" }, { "nct_id": "NCT04722146", "title": "A Study of Teclistamab With Other Anticancer Therapies in Participants With Multiple Myeloma", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Multiple Myeloma" ], "interventions": [ { "name": "Teclistamab", "type": "DRUG" }, { "name": "Daratumumab", "type": "DRUG" }, { "name": "Pomalidomide", "type": "DRUG" }, { "name": "Lenalidomide", "type": "DRUG" }, { "name": "Bortezomib", "type": "DRUG" }, { "name": "Nirogacestat", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 140, "start_date": "2021-03-12", "completion_date": "2027-10-13", "has_results": false, "last_update_posted_date": "2026-09-28", "last_synced_at": "2026-10-26T07:39:10.854Z", "location_count": 14, "location_summary": "Birmingham, Alabama • San Francisco, California • Denver, Colorado + 10 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "San Francisco", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT04722146" }, { "nct_id": "NCT03495154", "title": "Post Market Study of Parietene™ DS Composite Mesh in Ventral Hernia Repair", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Ventral Hernia" ], "interventions": [ { "name": "Parietene DS Composite Mesh", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Medtronic - MITG", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 145, "start_date": "2018-06-21", "completion_date": "2022-07-06", "has_results": true, "last_update_posted_date": "2024-04-23", "last_synced_at": "2026-10-26T07:39:10.854Z", "location_count": 6, "location_summary": "Baton Rouge, Louisiana • Columbia, Missouri • Columbus, Ohio + 3 more", "locations": [ { "city": "Baton Rouge", "state": "Louisiana" }, { "city": "Columbia", "state": "Missouri" }, { "city": "Columbus", "state": "Ohio" }, { "city": "Newport News", "state": "Virginia" }, { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT03495154" }, { "nct_id": "NCT07191067", "title": "Pivotal Study on the NOVABLOC System for Patients Undergoing Primary Total Knee Arthroplasty", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pain" ], "interventions": [ { "name": "Percutaneous radiofrequency electrical nerve stimulation", "type": "DEVICE" }, { "name": "Non-therapeutic stimulation", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Synaptrix, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 120, "start_date": "2025-09-30", "completion_date": "2026-12-31", "has_results": false, "last_update_posted_date": "2026-08-21", "last_synced_at": "2026-10-26T07:39:10.854Z", "location_count": 5, "location_summary": "Daphne, Alabama • Williamsville, New York • Chapel Hill, North Carolina + 2 more", "locations": [ { "city": "Daphne", "state": "Alabama" }, { "city": "Williamsville", "state": "New York" }, { "city": "Chapel Hill", "state": "North Carolina" }, { "city": "Medford", "state": "Oregon" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT07191067" }, { "nct_id": "NCT00698867", "title": "A Clinical Investigation of the Discovery™ Elbow System", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Osteoarthritis", "Rheumatoid Arthritis", "Avascular Necrosis", "Humeral Fractures" ], "interventions": [], "intervention_types": [], "sponsor": "Biomet Orthopedics, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 118, "start_date": "2002-06", "completion_date": "2016-07", "has_results": true, "last_update_posted_date": "2017-08-07", "last_synced_at": "2026-10-26T07:39:10.854Z", "location_count": 4, "location_summary": "Tampa, Florida • Indianapolis, Indiana • Boston, Massachusetts + 1 more", "locations": [ { "city": "Tampa", "state": "Florida" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT00698867" }, { "nct_id": "NCT00257621", "title": "GW640385 Plus Ritonavir And NRTIs For 48 Weeks In HIV-1 Infected Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Infection, Human Immunodeficiency Virus I", "HIV Infection" ], "interventions": [ { "name": "GW640385", "type": "DRUG" }, { "name": "Ritonavir", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "ViiV Healthcare", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2004-10", "completion_date": "2007-01", "has_results": false, "last_update_posted_date": "2017-05-30", "last_synced_at": "2026-10-26T07:39:10.854Z", "location_count": 9, "location_summary": "Phoenix, Arizona • San Francisco, California • Washington D.C., District of Columbia + 6 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "San Francisco", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Fort Lauderdale", "state": "Florida" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00257621" }, { "nct_id": "NCT07827014", "title": "An Open-Label, Two-Arm Pilot Study of the Tolerability, Consumer Acceptability, and Exploratory Well-Being Outcomes of a Multi-Ingredient Protein Formula in Two Flavors in Healthy Adults", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Vanilla Protein Formula", "type": "DIETARY_SUPPLEMENT" }, { "name": "Chocolate Protein Formula", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Qualia Life Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "21 Years to 65 Years" }, "enrollment_count": 50, "start_date": "2026-10", "completion_date": "2027-01", "has_results": false, "last_update_posted_date": "2026-09-18", "last_synced_at": "2026-10-26T07:39:10.854Z", "location_count": 1, "location_summary": "Carlsbad, California", "locations": [ { "city": "Carlsbad", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07827014" }, { "nct_id": "NCT07221838", "title": "A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Generalized Myasthenia Gravis", "gMG" ], "interventions": [ { "name": "Oral Corticosteroid Tapering Schedule", "type": "PROCEDURE" }, { "name": "Ravulizumab", "type": "DRUG" }, { "name": "Prednisone/Prednisolone", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DRUG" ], "sponsor": "Alexion Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 75, "start_date": "2026-03-04", "completion_date": "2027-08-27", "has_results": false, "last_update_posted_date": "2026-04-09", "last_synced_at": "2026-10-26T07:39:10.854Z", "location_count": 5, "location_summary": "Chicago, Illinois • Schaumburg, Illinois • Neptune City, New Jersey + 2 more", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Schaumburg", "state": "Illinois" }, { "city": "Neptune City", "state": "New Jersey" }, { "city": "Raleigh", "state": "North Carolina" }, { "city": "Knoxville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT07221838" } ] }